Tirzepatide – 50mg (10 vials)

Product Overview

Tirzepatide is a synthetic peptide-based compound investigated for its activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This listing identifies the product as Tirzepatide 50mg in a 10-vial package. The exact quantity per vial and total package content should be confirmed against the supplier’s original label.

Scientific Background

Tirzepatide has been studied for its role in metabolic regulation and glucose-dependent hormone signaling. Its pharmacological activity is distinct from that of general research peptides, and approved medicinal products have specific regulatory, manufacturing, storage, and prescribing requirements.

Scientific information about tirzepatide does not establish the quality, sterility, authenticity, or suitability of any particular commercial vial.

Product Specifications

• Product Name: Tirzepatide
• Listed Strength: 50mg
• Package Quantity: 10 vials
• Product Type: Peptide-based compound
• Research Area: Metabolic and hormone-signaling research
• Formulation and Quantity per Vial: Verify using the supplier’s original label and documentation

Product Identification and Documentation

Check the original supplier documentation to verify the product’s identity, stated strength, formulation, packaging, storage requirements, and applicable regulatory authorization. Do not claim sterility, purity percentages, independent testing, or specific manufacturing standards without supporting evidence.

Important Regulatory Disclaimer

Tirzepatide is a regulated medicinal compound in many markets. It should not be presented as an unapproved research product for human use, and this listing does not establish that the supplied material is an authorized medicine. Sale and marketing must comply with applicable laws and regulatory requirements.

Do not use this description as medical advice or as a recommendation for self-administration. Any authorized medicinal product must be used according to its approved labeling and the direction of a qualified healthcare professional.